Analysts think FBRX stock price could increase by 1029%
Nov 21, 2024, 12:26 PM
42.73%
What does FBRX do
Forte Biosciences, a Dallas-based biopharmaceutical company, specializes in dermatology products and is advancing product candidate FB-102 for autoimmune diseases. The company went public on April 13, 2017, and holds a U.S. patent for skin treatment.
3 analysts think FBRX stock price will increase by 1029.15%. The current median analyst target is $153.00 compared to a current stock price of $13.55. The lowest analysts target is $151.50 and the highest analyst target is $157.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.